AVR Anteris Technologies Global Corp. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
AVR Stock | Fundamental Analysis & Investment Insights
NASDAQ
Healthcare
Medical Instruments & Supplies
Current Price
Live
$6.46
Analyst Target
$15.25
+136.1%
Upside
52W High
$8.79
52W Low
$2.34
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
68%
Analysis Accuracy
The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 1/9, indicating severe operational and profitability deterioration. Despite a bullish analyst consensus and strong recent price momentum, the company is deeply unprofitable, with negative operating margins exceeding -5000%, collapsing revenue, and consistently missing earnings estimates over the past four quarters. Valuation metrics are extremely stretched, with a Price/Book of 62.72 and Price/Sales of 293.31, while the lack of Altman Z-Score due to structural or data limitations raises unresolved bankruptcy risk concerns. The stock's recent 6M surge of +98.8% appears disconnected from fundamentals, suggesting speculative pricing rather than value-based appreciation.
Key Strengths
High gross margin of 67.93% indicates strong pricing power or low production costs in core operations
Bullish analyst recommendation consensus (strong_buy) with a high target price of $15.25 implying 136% upside
Recent price momentum is strong, with +98.8% return over 6 months and +26.4% in one week
Debt/Equity ratio of 0.70 is below sector average of 1.17, suggesting moderate leverage risk
Operating in the high-growth medical instruments sector, which has an average revenue growth of 41.00%
Key Risks
Piotroski F-Score of 1/9 signals extreme financial distress and poor profitability, asset utilization, and leverage trends
Operating margin of -5189.98% and ROE of -2698.53% reflect catastrophic profitability collapse
Revenue growth YoY is -44.20%, indicating rapid top-line contraction
Current ratio of 0.84 and quick ratio of 0.70 suggest near-term liquidity risk
Company has missed earnings estimates in all of the last four quarters, averaging a -15.15% surprise
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare AVR against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning AVR from our newsroom.
Newest → oldest
No matching news yet.